27 Nov 2022
Therapy of valvular heart diseases: a patient-centred innovation journey
Sponsored by Edwards Lifesciences
Anchorperson:
B. Prendergast
Moderator:
J. Kempfert
Summary
Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.
Learning Objectives
- To explore how patients have historically been at the centre of technological development for the unmet needs of treating valvular heart disease
- To discuss how innovations enable increasingly sophisticated treatment options that an interdisciplinary heart team can tailor to the needs of each patient against the background of a comprehensive lifetime management
- To deliberate the therapeutic options that are available for patients with progressive or multivalvular heart diseases
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)
/slide025.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)